The Medication Question: MAT, Psychiatric Medication, and the Stigma That Costs Lives
The stigma surrounding medication in addiction recovery and mental health treatment is clinically costly. Medication-assisted treatment is among the most evidence-supported interventions available for opioid use disorder. The refusal to use it, driven by stigma rather than evidence, produces preventable deaths.
The Medication Question
The stigma surrounding medication in addiction recovery and mental health treatment is clinically costly. It shapes treatment decisions in ways that are inconsistent with the evidence and, in the case of opioid use disorder, produces preventable deaths.
Medication-assisted treatment (MAT) for opioid use disorder — using buprenorphine, methadone, or naltrexone — is among the most evidence-supported interventions in the behavioral health field. The research is consistent: MAT reduces overdose mortality, reduces illicit drug use, improves treatment retention, and improves social functioning. The effect sizes are large.
The Abstinence-Only Problem
A significant portion of the addiction treatment field remains committed to abstinence-only approaches that exclude or discourage MAT. This position is not supported by the evidence. It reflects a moral framework about what constitutes legitimate recovery rather than a clinical assessment of what produces the best outcomes.
For families navigating opioid use disorder, the abstinence-only framework is a clinical risk. Treatment programs that exclude MAT are offering a less effective intervention than the evidence supports. The decision to use or not use MAT should be made on clinical grounds, not ideological ones.
Psychiatric Medication in Recovery
The question of psychiatric medication in recovery is distinct from MAT but similarly complicated by stigma. Many individuals with substance use disorders have co-occurring psychiatric conditions — depression, anxiety, PTSD, bipolar disorder — that require pharmacological treatment. The untreated psychiatric condition is a relapse risk. Treating it with appropriate medication is a clinical necessity, not a compromise of recovery.
The interaction between psychiatric medication and recovery requires careful clinical management. Not all medications are appropriate in all recovery contexts. The management of this complexity requires a clinician who understands both addiction medicine and psychiatry.
Contact Coast Health Consulting to discuss medication management and integrated treatment planning.
Bobby Tredinnick, LMSW, CASAC
Bobby Tredinnick is a Licensed Master Social Worker and Certified Alcohol and Substance Abuse Counselor with extensive experience in behavioral health case management, intervention services, and clinical support for young adults and families navigating complex mental health and addiction challenges.
Related Articles
Coast Health InsightsThe Burnout Misdiagnosis: When Exhaustion Is Something More Serious
Burnout has become a cultural diagnosis — a catch-all term for the exhaustion and disengagement that high-performing professionals experience. The problem is that burnout frequently co-occurs with, or masks, clinical depression, anxiety disorders, and substance use disorders that require specific treatment.
Coast Health InsightsThe Sober Living Question: When Structured Housing Supports Recovery and When It Doesn't
Sober living homes occupy an important but poorly understood position in the recovery continuum. The quality and clinical appropriateness of sober living arrangements varies enormously, and the decision to use them requires careful evaluation.
Coast Health InsightsThe Enabling Economy: How Financial Support Prolongs Behavioral Health Crises
Financial support from family members is one of the most powerful forces sustaining active behavioral health disorders. Understanding the mechanism — and the clinical alternative — is essential for families who want to help without prolonging the crisis.
Coast Health InsightsThe Privacy Problem: Why Behavioral Health Confidentiality Is More Complicated Than It Appears
The assumption that behavioral health treatment is private is widely held and frequently incorrect. For professionals, public figures, and anyone with significant reputational or legal exposure, understanding the actual limits of confidentiality is essential before entering treatment.
Coast Health InsightsThe Isolation Paradox: Why Success Can Narrow the World
High-functioning individuals with behavioral health disorders often experience a particular form of isolation — one that is invisible from the outside and deeply resistant to standard interventions. Understanding this paradox is essential for effective treatment planning.
Coast Health InsightsThe Mental Health Companion: A Different Kind of Support
The mental health companion role addresses a gap in the standard continuum of care — the space between clinical treatment and independent functioning. For individuals managing serious mental health conditions, this support can be the difference between sustained stability and repeated crisis.